Remote Patient Monitoring for Chronic Hypertension During Pregnancy (REACH) (NCT07115199) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Remote Patient Monitoring for Chronic Hypertension During Pregnancy (REACH)
United States50 participantsStarted 2026-11-01
Plain-language summary
We hypothesize that frequent remote monitoring of blood pressure and real-time antihypertensive medication titration will optimize pregnancy outcomes in a clinically meaningful and cost-effective manner compared to the current standard of care. Therefore, this pilot study, as part of the K12 training support, will evaluate the feasibility of a randomized clinical trial to treat mild chronic hypertension with medication therapy to a blood pressure goal of less than 140/90 mmHg based on remote daily patient monitoring compared to in-office blood pressure readings.
Who can participate
Age range
18 Years – 55 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 18 or older
* Patients with a viable pregnancy \<23 weeks of gestation
* Chronic hypertension is defined as: 1) Currently receiving treatment for hypertensive disorders OR 2) Newly diagnosed or untreated chronic hypertension is defined as systolic blood pressure \>=140 mm Hg or diastolic blood pressure \>=90 mm Hg prior to 20 weeks of gestation
* Viable pregnancy \<23 weeks of gestation
* Ability to follow directions
* Ability to consent
* Speak English or Spanish
Exclusion Criteria:
* Known secondary cause of hypertension
* Known major fetal anomaly
* Known fetal demise
* Suspected fetal growth restriction
* Membrane rupture
* Planned termination
* Plan to deliver outside of the RWJ Barnabas Health system
* Known sensitivity to labetalol or nifedipine
* Unlikely to follow up, in the opinion of the study staff.
* Any medical condition that the providers feel is a contraindication to the REACH algorithm.
* Unwillingness to take blood pressure at home
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Composite perinatal outcomes
Timeframe: Delivery until 28 days after birth
Trial details
NCT IDNCT07115199
SponsorRutgers, The State University of New Jersey